glp 1 inhibitors Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment GLP-1 Receptor Agonists as Treatments

IntroductionGlucagon-like peptide-1 receptor agonists (GLP-1 RA) are novel agents with proven cardiovascular (CV) benefits

Pfizer plans to conduct dose optimization studies in the second half of 2024 evaluating multiple doses of the preferred modified release formulation to inform the registration enabling studies

The glucagon-like peptide-1 receptor agonist (GLP-1) liraglutide may protect the brains of people with mild Alzheimers disease (AD) and reduce cognit

Consistent use of GLP-1 support contributes to overall wellness, metabolic efficiency, and sustained vitality

Mechanistic hypotheses include reduced leptin-driven T-helper (Th)1/Th17 activity, improved adipokine balance, and modulation of gut-thyroid axis pathways

Providers on our platform can now send prescriptions for Zepbound vials and KwikPen, as well as Foundayo, to the LillyDirect pharmacy and access self-pay pricing for Hims & Hers customers.